We are live on ! Find out more
BFRIW icon

Biofrontera

5 hedge funds and large institutions have $136K invested in Biofrontera in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.28% less ownership

Funds ownership: 1.94%1.66% (-0.28%)

17% less funds holding

Funds holding: 65 (-1)

42% less capital invested

Capital invested by funds: $236K → $136K (-$100K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.09%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
1
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$268
Name Holding Trade Value Shares
Change
Change in
Stake
BA
1
Bard Associates
Illinois
$71K
EAM
2
Empery Asset Management
New York
$45K
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$14K -$2.06K -3,303 -13%
CS
4
Clear Street
New York
$4K
UBS Group
5
UBS Group
Switzerland
$2K +$268 +430 +11%
WAM
6
Warberg Asset Management
Illinois
-$10K -13,451 Closed

BFRIW Hedge Fund Activity: Q3 2022 in Review

5 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Biofrontera (BFRIW) for Q3 2022, worth a combined $136K — down 42% from $236K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BFRIW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $268. The largest seller was Warberg Asset Management, exiting entirely with an estimated $10K sold.

  • 5 institutional investors held Biofrontera (BFRIW) as of Q3 2022, down from 6 in Q2 2022.
  • Funds reported $136K of Biofrontera stock for Q3 2022, down 42% quarter-over-quarter.
  • 0 funds opened new Biofrontera positions in Q3 2022 and 1 closed out, a net change of -1 holder.
  • The largest Biofrontera buyer in Q3 2022 was UBS Group, an estimated $268 added.
  • The largest Biofrontera seller in Q3 2022 was Warberg Asset Management, an estimated $10K sold.

Based on aggregated 13F filings for Q3 2022.